Retinoic Acid Receptor alpha anticorps (C-Term)
Aperçu rapide pour Retinoic Acid Receptor alpha anticorps (C-Term) (ABIN791005)
Antigène
Voir toutes Retinoic Acid Receptor alpha (RARA) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Affinity purified
-
Immunogène
-
A 15 amino acid peptide from near the C terminal residues of human retinoic acid receptor alpha protein
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: ELISA (1:40000), IHC (1:50 - 1:200), WB (1:200 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- Retinoic Acid Receptor alpha (RARA) (Retinoic Acid Receptor, alpha (RARA))
-
Autre désignation
- RARA / RAR Alpha
-
Sujet
-
Name/Gene ID: RARA
Subfamily: NR1 Thyroid hormone-like
Family: NHR
Synonyms: RARA, NR1B1, PML-RAR, RAR-alpha, RARalpha, Retinoic acid receptor alpha, Pml-rara, RAR, RAR alpha, Retinoic acid receptor, alpha -
ID gène
- 5914
-
UniProt
- P10276
-
Pathways
- Nuclear Receptor Transcription Pathway, Retinoic Acid Receptor Signaling Pathway, Intracellular Steroid Hormone Receptor Signaling Pathway, Steroid Hormone Mediated Signaling Pathway, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, S100 Proteins
Antigène
-